Heat-shock protein 90 enables ER+ breast cancers to develop resistance to hormonal th

[News]

Long known for its ability to help organisms successfully adapt to environmentally stressful conditions, the highly conserved molecular chaperone heat-shock protein 90 (HSP90) also enables estrogen receptor-positive (ER+) breast cancers to develop resistance to hormonal therapy.

More... (http://www.news-medical.net/news/20141210/Heat-shock-protein-90-enables-ER2b-breast-cancers-to-develop-resistance-to-hormonal-therapy.aspx)